Login to Your Account

Other News To Note

Tuesday, June 5, 2012
• China Nuokang Bio-Pharmaceutical Inc., of Beijing, said the independent committee of the company's board of directors evaluating the acquisition proposal from Chairman and CEO Baizhong Xue appointed Lazard and Houlihan Lokey as its independent financial advisors. In May, Xue proposed to acquire the outstanding shares not currently owned by Xue or companies under his control.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription